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Benzene is a widely recognized human carcinogen, the effect of which is attributed to the production of reactive oxygen species (ROS)
from its metabolites. Although there have been many reports on the relationship between DNA damage induced by benzene metabolites and
carcinogenesis, only a report approached the subject by examining the benzene-induced dysregulation of apoptosis. Inhibition of apoptosis,
aberrantly prolonging cell survival, may contribute to cancer by facilitating the insurgence of mutations and by creating a permissive
environment for genetic instability. In this study, we examined the mechanism of antiapoptotic effects by benzene metabolites, p-
benzoquinone (BQ) and hydroquinone (HQ), and their relationships with carcinogenesis. BQ and HQ inhibited the apoptotic death of
NIH3T3 cells induced by both serum starvation and lack of an extracellular matrix (ECM). An antioxidant agent, N-acetylcysteine,
significantly inhibited the antiapoptotic effects induced by benzene metabolites, indicating that the effects were mainly due to the production
of ROS. Furthermore, BQ and HQ inhibited the in vitro caspase-3 activation, suggesting that the inhibition of caspase-3 activation due to
ROS produced by BQ- and HQ-treatment was related to the suppression of apoptosis. The cells that escaped apoptosis could survive with the
addition of serum and attachment to the ECM. Levels of 8-oxo-7,8-dihydro-2V-deoxyguanosine were higher in the cells which survived after
BQ- and HQ-treatment than in the normal cells. Furthermore, the cells treated with BQ and HQ showed greater proliferation than normal cells
under low-serum conditions and anchorage-independent growth in soft agar. These findings suggested that benzene metabolites induced
dysregulation of apoptosis due to caspase-3 inhibition, which contributes to carcinogenesis.
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1. Introduction mental animals [3]. The majority of benzene metabolismBenzene is a ubiquitous environmental chemical that is
used mainly as a precursor in the synthesis of numerous
products including drugs, dyes, insecticides and plastics. It
is also found in unleaded gasoline, cigarette smoke and
industrial emissions. Exposure to benzene is suggested to be
leukemogenic to humans [1,2] and tumorigenic to experi-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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Abbreviations: BQ, p-benzoquinone; HQ, hydroquinone; ROS, reactive
oxygen species; 8-oxo-dG, 8-oxo-7,8-dihydro-2V-deoxyguanosine; ECM,
extracellular matrix; BSA, bovine serum albumin; FDA, fluorescein
diacetate; cyt c, cytochrome c; CDCFH-DA, 6-carboxy-2,7V-dichlorodihy-
drofluorescein diacetate, di (acetoxymethyl ester); Ac-DEVD-MCA, acetyl-
Asp-Glu-Val-Asp-a-(4-methyl-coumaryl-7-amide); CS, calf serum; FCM,
flow cytometer
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the principal enzyme involved in the oxidization of benzene
to its major hydroxylated metabolites, i.e. phenol, catechol,
hydroquinone (HQ) and 1,2,4-benzenetriol [4]. Without this
enzyme, no cytotoxicity or genotoxicity was observed in
mice [5]. The phenolic metabolites accumulate in the bone
marrow [6], where myeloperoxidase and other peroxidases
convert them to reactive semiquinones and quinines [7],
which can further lead to the formation of reactive oxygen
species (ROS) [8,9]. These ROS are postulated to mediate
key steps in the mechanism of benzene toxicity.
ROS are known to damage protein, lipids and DNA,
which may initiate carcinogenesis. Benzene metabolites
have been shown to induce oxidative DNA damage, lipid
peroxidation, increases in the levels of antioxidant enzymes
and so on, supporting a role for ROS in benzene toxicity
[8–10]. Hiraku and Kawanishi [9] reported that p-benzo-
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 and H2O2 via the
formation of semiquinone, which contribute to the forma-
tion of 8-oxo-7,8-dihydro-2V-deoxyguanosine (8-oxo-dG)
[10], an oxidative product of the guanine residue, and the
beginning of carcinogenesis [11]. The mechanism of ben-
zene carcinogenesis is unclear, but these ROS can provoke
the initiation of cancer.
We have previously reported that UVB irradiation sup-
pressed apoptosis induced by detachment from the extra-
cellular matrix (ECM) under serum-free conditions [12].
Apoptosis is the most important cell death system for
preventing the cancer caused by UV-induced damage and
its suppression might increase the neoplastic risk [13]. UVB
irradiation is known to damage genomic DNA, which has
been considered the main factor in the initiation of UVB-
induced skin cancer, but no approach had been made taking
into account the suppression of apoptosis. A defect of
apoptosis contributes to tumor progression by permitting
the survival of mutated cells, for example, cells that harbor
an activated oncogene, and their accumulation by slowing
the rate of cell turnover [14–17]. Benzene is also widely
recognized as a human carcinogen. There have been many
reports that cancer caused by benzene is mainly due to ROS-
induced oxidative DNA damage [9,10] or the formation of
DNA adducts [18] and specific mutations [19–21]. Only a
study on the inhibition of cell death by benzene metabolites
was reported [22], but their relationships with carcinogen-
esis have not yet been proved. We have reported that the
antiapoptotic mechanism of UVB irradiation could partially
be attributed to the production of ROS [23]. Therefore,
benzene metabolites, which also generate ROS [8,9], might
have an antiapoptotic effect the same as UVB irradiation in
our experimental methods and the elucidation of the effect
would result in making clear the relationships with benzene-
induced carcinogenesis.
In this study, we found that both BQ and HQ inhibited the
cell death caused by serum depletion and loss of cell
adhesion. BQ- and HQ-treatment induced intracellular pro-
duction of peroxides and an antioxidant agent, NAC, sig-
nificantly prevented the antiapoptotic effects, suggesting
that ROS contributed to the induction of the antiapoptotic
effect. Furthermore, cells that survived apoptotic cell death
following treatment with BQ or HQ showed a significant
enhancement of 8-oxo-dG formation and transformation
supported by growth independent of nutrition and anchor-
age-independent growth in soft agar. Our goal in this study
is to show a new concept in cancer initiation and progression
by benzene metabolites, that is, dysregulation of apoptosis.2. Materials and methods
2.1. Materials
BQ, HQ, bovine serum albumin (BSA) and fluorescein
diacetate (FDA) were purchased from Wako Pure ChemicalsInd., Ltd. (Osaka, Japan). bis-Benzimide (Hoechst33342),
cytochrome c (cyt c), nuclease P1 and alkaline phosphatase
were obtained from Sigma-Aldrich Co. (St. Louis, MO). 6-
Carboxy-2,7V-dichlorodihydrofluorescein diacetate, di (ace-
toxymethyl ester) (CDCFH-DA) was purchased from Mo-
lecular Probes, Inc. (Eugene, OR). The caspase-3 substrate,
acetyl-Asp-Glu-Val-Asp-a-(4-methyl-coumaryl-7-amide)
(Ac-DEVD-MCA), was obtained from Peptide Inst. Inc.
(Osaka, Japan). Proteinase k was purchased from Merck
(Germany). Alamar Blue was a product of Diagnostic
Systems, Inc. (Westlake, OH).
2.2. Cells and culture conditions
NIH3T3 cells were cultured with Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% calf
serum (CS) at 37 jC in a humidified atmosphere containing
5% CO2 in air. For the experiments, the cells were seeded at
3 106 cells/100 mm tissue culture dish. After culture for 6
h, the medium was changed to serum-free DMEM. Follow-
ing a further culture for 18 h, the cells were trypsinized and
plated in cell suspension dishes previously coated with heat-
denatured BSA (2 mg/ml) at 37 jC for 1 h (1105 cells/
well of 24-well plates or 5 105 cells/35 mm dish). BQ- or
HQ-treated cells were prepared as follows: the cells were
cultured for 2 h in the presence of BQ or HQ and washed
twice with serum-free DMEM.
2.3. Viability assay
BQ- or HQ-treated cells cultured for 22 h in the absence
of CS were suspended in PBS containing FDA (0.1Ag/ml)
and incubated for 10 min at 37 jC. Viability was deter-
mined using a flow cytometer (FCM) (Epics XL; Coulter,
Hialeah, FL).
2.4. Determination of apoptotic cells
Apoptosis was measured by detecting both chromatin-
condensed cells and DNA fragmentation.
For the detection of chromatin-condensed cells, BQ- or
HQ-treated cells were cultured for 22 h in the absence of CS
and stained with the DNA-binding fluorochrome
Hoechst33342 as described previously [12]. Briefly, cells
were fixed in 2% glutaraldehyde for 4 h, and then suspended
in PBS containing 1 mM Hoechst33342. Following incu-
bation for 10 min at room temperature, the cells were scored
microscopically.
For the detection of DNA fragmentation, BQ- or HQ-
treated cells were cultured for 6 h in the absence of CS,
washed twice with PBS and resuspended in a 1% low-melting
agarose (InCert agarose, BioWhittaker Molecular Applica-
tions, Inc., Rockland, ME) solution (5 105 cells/90 Al).
They were placed in an agarose plug maker and kept at 4 jC
for 30 min. Solidified agarose plugs were incubated in
proteinase k solution (0.5 M Na-EDTA (pH 8.0), 1% Sarco-
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jC and further incubated in TE (10 mM Tris–HCl and 1 mM
EDTA (pH 8.0)) containing PMSF (40 Ag/ml) for 30 min at
50 jC. After three washes with TE, the plugs were placed in
0.8% agarose gel (SeaKem GTG agarose, Cambrex Bio
Science Rockland, Inc., Rockland, ME). Electrophoresis
was performed in 0.5 Tris-borate EDTA buffer with a
biased sinusoidal field gel electrophoresis system (Atto. Co.,
Japan). The DNA in the gel was visualized using ethidium
bromide.
2.5. Determination of caspase-3 activity
Caspase-3 activity was measured by a direct assay in cell
lysates as previously described [12]. Briefly, following
incubation of BQ- or HQ-treated cells in the absence of
CS for 6 h, the cells were lysed in lysis buffer (10 mM Tris–
HCl, pH 7.5, 130 mM NaCl, 1% Triton X-100, 10 mM
Na4P2O7, and 10 mM Na2HPO4). Aliquots of cell lysate
were incubated in reaction buffer (20 mM HEPES and 10%
glycerol) in the presence of Ac-DEVD-MCA (250 AM) for
1 h at 37 jC. The amounts of fluorogenic MCA moiety
released were measured using a spectrofluorometer
(FL4500, Hitachi, Tokyo, Japan) (ex. 380 nm, em. 460 nm).
2.6. Determination of caspase-3 activation in vitro
Activation of caspase-3 in vitro was assayed using the S-
100 fraction, prepared as described by Liu et al. [24]. BQ- or
HQ-treated cells (5 106 cells) were suspended in 500 Al of
ice-cold buffer A (20 mM Hepes-KOH, pH 7.5, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA and 0.1
mM PMSF), supplemented with protease inhibitors (2 Ag/ml
pepstatin A, leupeptin and aprotinin). After standing on ice
for 15 min, the cells were disrupted using a Dounce
homogenizer. The lysates were centrifuged at 1000 g for
10 min and the supernatants were further centrifuged at
100,000 g for 30 min (S-100 fraction). Aliquots of the S-Fig. 1. Survival of NIH3T3 cells treated with benzene metabolites. NIH3T3 cells
treated with BQ (A) or HQ (B) for 2 h as a function of concentration, washed out a
FDA and incubated for 10 min at 37 jC. Viability was determined by FCM. Val
differences between groups. *P < 0.05, **P< 0.001.100 fraction (50 Ag) were incubated in the presence of 1
mM dATP, 0.1 mg/ml of cyt c and 5 mMMgCl2 at 30 jC for
1 h and the caspase activity was assayed using fluorogenic
substrates (Ac-DEVD-MCA) as described above.
2.7. Flow cytometric detection of intracellular peroxide
Immediately after treatment with BQ or HQ for 1 h, the
cells were incubated for 1 h in the presence of CDCFH-DA
(10 AM), and analyzed by FCM.
2.8. Determination of 8-oxo-dG by ELISA
BQ- or HQ-treated cells were cultured for 22 h in the
serum-free medium. After further culture for 24 h under
adherent conditions in the presence of CS, the attached cells
(living cells) were recovered and DNA was isolated using a
DNA Extractor WB kit (Wako Pure Chemicals). The iso-
lated DNA was suspended in 135 Al of 20 mM sodium
acetate (pH 4.8) and digested to nucleotide with nuclease P1
(40 U/ml) at 37 jC for 2 h. Then, 15 Al of 1 M Tris–HCl
(pH 7.4) was added and the samples were treated with
alkaline phosphatase (25 U/ml) at 37 jC for 2 h. The level
of 8-oxo-dG in digested DNA was determined using an 8-
oxo-dG ELISA kit (Japan Institute for Control of Aging,
Japan).
2.9. Assessment of cell growth under low-serum conditions
Alamar Blue, which can be used to monitor the activity
of dehydrogenase in the mitochondria of living cells, was
used for the detection of cell proliferation. HQ-treatment for
surviving cells under serum-free conditions with loss of the
ECM was repeated three times once a week. Normal
NIH3T3 cells and the cells which survived from apoptotic
cell death after treatment with HQ (1104 cells/100 Al/96
well) were cultured in several concentrations of serum for 6
h, then incubated with Alamar Blue (10 Al). After incuba-cultured for 18 h in serum-free DMEM were plated in BSA-treated dishes,
nd cultured in serum-free DMEM for a further 22 h. They were loaded with
ues are meansF S.D. (n= 3). ANOVA was used to test the significance of
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microplate fluorescence reader (FL500, BIO-TEC, Japan)
(ex. 530 nm, em. 590 nm) at 24 h intervals.
2.10. Determination of colony-forming ability in soft agar
To test the colony-forming ability of the cells which
survived from apoptotic cell death in soft agar, a double
layer culture technique was carried out employing a bottom
layer of 0.6% Noble agar and a top layer of 0.3% agar in
DMEM supplemented with 10% CS. Normal NIH3T3 cells
and the cells which survived after treatment with HQ were
plated at 1104 cells/60 mm dish. After 3 weeks, the
colonies were enumerated and photographed.
2.11. Statistics
All experiments were repeated two or three times.
ANOVA was used to test the significance between groups
(n = 3–8).
Fig. 3. Suppression of caspase-3 activation by benzene metabolites. The
cells plated in BSA-treated dishes were treated with BQ or HQ for 2 h,
washed out and further cultured for 4 h in serum-free DMEM. The cells
were lysed in lysis buffer on ice. An aliquot of cell lysate (25 Ag proteins)
was added to a reaction buffer containing 250 AM fluorogenic substrate
(Ac-DEVD-MCA) and incubated for 1 h at 37 jC. The amounts of
fluorogenic MCA moiety released were measured using a spectrofluorom-
eter and converted to micromoles of MCA released using the standard curve
of 7-amino-4-methylcoumarin. Values are meansF S.D. (n= 3). *P < 0.001
(vs. untreated).3. Results
3.1. Suppression of apoptosis by benzene metabolites
Fig. 1 shows the survival of benzene metabolite-treated
cells cultured under serum-free and detached conditions.Fig. 2. Suppression of apoptosis by benzene metabolites. (A) Determination of chromatin-condensed cells. BQ- and HQ-treated cells were cultured for 22 h in
the absence of CS, fixed in 2% glutaraldehyde and stained with 1 mM Hoechst33342 for 10 min. Aliquots were placed on glass slides, and 200 cells per slide
were scored microscopically in quadruplicate. Values are meansF S.D. (n= 4). *P < 0.001 (vs. untreated). (B) Detection of DNA fragmentation. BQ- and HQ-
treated cells were cultured for 6 h in the absence of CS and built-in 1% agarose solution (5 105 cells/90 Al). Biased sinusoidal field gel electrophoresis was
performed as described in Materials and methods.
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determined as 100%. About 80% of NIH3T3 cells cul-
tured in BSA-coated dishes (detached from ECM) under
serum-free conditions for 24 h underwent cell death.
Benzene metabolites, BQ and HQ, below a concentration
of 100 AM inhibited the cell death in a dose-dependent
manner. On the other hand, above 100 AM, the increased
survival was reduced dose-dependently. The occurrence ofFig. 4. Increase of intracellular peroxides by benzene metabolites. The cells plat
incubated for 1 h in the presence of CDCFH-DA (10 AM). They were analyzed
(A) NAC 0 mM, (B) 10 mM, (C) 25 mM.chromatin condensation (Fig. 2A) suggested that the cell
death induced by cell detachment and serum depletion
was due to apoptosis, which was dose-dependently sup-
pressed by treatments with benzene metabolites. DNA
cleavage into oligonucleosomal fragments (123 bp) is a
characteristic of cells undergoing apoptosis. However, no
internucleosomal fragmentation was observed in this ex-
periment (data not shown). Culture in serum-starveded in BSA-coated dishes were treated with BQ or HQ for 1 h and further
with FCM. NAC was added from 30 min before BQ- or HQ-treatment.
Fig. 6. Inhibition of in vitro activation of caspase-3 by benzene metabolites.
The cells plated in BSA-coated dishes were treated with HQ or BQ for 2 h.
Immediately, the S-100 fraction was prepared as described in Materials and
methods. Aliquots of the S-100 fraction (50 Ag) were incubated in the
presence of 1 mM dATP, 0.1 mg/ml of cyt c and 5 mM MgCl2 for 1 h at
30 jC. They were incubated in the presence of 250 AM fluorogenic substrate
(Ac-DEVD-MCA) for 1 h at 37 jC and amounts of fluorogenic MCA
moiety released were measured using a spectrofluorometer. Black column:
in the absence of dATP and cyt c, gray column: in the presence of dATP and
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large fragments (50–150 kbp) in murine fibrosarcoma
cells, but not internucleosomal fragmentation [25]. In the
present study, the depletion of ECM and serum starvation
produced large fragments, which disappeared on treat-
ment with BQ or HQ (Fig. 2B). The activation of
caspase-3 was significantly enhanced at 6 h after detach-
ment from the ECM in serum-free conditions as reported
previously [12]. Both BQ and HQ inhibited the activation
in a dose-dependent manner, with concentrations above
100 AM significantly suppressing the activation (Fig. 3).
In spite of the fact that above 300 AM, BQ and HQ
induced cell death as shown in Fig. 1, chromatin-con-
densation, DNA fragmentation and caspase-3 activation
were actually suppressed.
3.2. ROS production on treatment with benzene metabolites
and its relationship with the antiapoptotic effect
Fig. 4A shows the distribution of the cells treated with
100 AM BQ or HQ and subsequently with CDCFH-DA, a
probe to detect the intracellular production of peroxides.
Both BQ- and HQ-treated cells showed a significant
increase in fluorescence intensity, indicating that ROS
were produced following treatment with the benzene
metabolites. An antioxidant, NAC, completely suppressed
the production of peroxides (Fig. 4B and C). To examine
the relationship between production of ROS stimulated by
benzene metabolites and the antiapoptotic effects, cell
survival and caspase-3 activity were evaluated in the
presence of NAC (Fig. 5). NAC significantly inhibited
the suppression of cell death and the decrease in activation
of caspase-3 induced following treatment with BQ or HQ,
showing that ROS production was the main factor con-
tributing to the induction of the metabolites’ antiapoptotic
effects.Fig. 5. Inhibition of benzene metabolite-induced antiapoptotic effects by NAC. The
min before BQ or HQ-treatment. (A) Survival. The cells were treated with BQ or H
serum-free DMEM. They were loaded with FDA and incubated for 10 min at 37 j
treated with BQ or HQ in the presence of NAC for 2 h and further cultured for 4
Black column: NAC 0 mM, gray column: NAC 10 mM, shaded column: NAC 2
NAC).3.3. Suppression of in vitro caspase activation by benzene
metabolites
The activation of caspase-3 was clearly inhibited by
treatment with benzene metabolites as shown in Figs. 3
and 5B. We have previously indicated that the ROS pro-
duced in response to UVB irradiation directly inhibited the
proteolysis of procaspase via its oxidation [23]. Therefore,
we examined whether caspase-3 activity was directly
inhibited by the treatment with BQ or HQ using a cell-free
system (Fig. 6). Cell extracts were prepared immediately
after treatment with BQ or HQ for 2 h and incubated in the
cyt c. Values are meansF S.D. (n= 3).cells plated in BSA-coated dishes were cultured in the presence of NAC 30
Q in the presence of NAC for 2 h, washed out and further cultured for 22 h in
C. Survival was determined by FCM. (B) Caspase-3 activity. The cells were
h. Caspase-3 activity was determined as described in the legend to Fig. 3.
5 mM. Values are meansF S.D. (n= 3). *P< 0.001 (vs. in the absence of
Fig.8. Increase of 8-oxo-dG in cells which survived following treatment
with the benzene metabolites. The cells which survived from apoptotic cell
death following treatment with BQ or HQ were cultured for a further 24 h in
the presence of CS and ECM. DNAwas isolated and digested as described
in Materials and methods and ELISA was performed according to the
manufacturer’s directions. Values are meansF S.D. (n= 3). *P < 0.01 (vs.
normal NIH3T3 cells).
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cantly activated in the presence of both dATP and cyt c, but
not in the absence of either dATP or cyt c, as shown in a
previous report [23], indicating that the activation could be
attributed to the dATP and cyt c. Treatment with BQ or HQ
inhibited the activation in vitro in the presence of both dATP
and cyt c. These results showed that benzene metabolites
directly inhibited the activation of caspase-3.
3.4. Accumulation of 8-oxo-dG in viable cells following
treatment with benzene metabolites
The BQ- or HQ-treated cells cultured under serum-free
and detached conditions for 24 h were further cultured under
adherent conditions in the presence of serum for more than
48 h. Fig. 7A shows cells cultured for 24 h after the addition
of serum. Untreated cells died, whereas BQ- or HQ-treated
cells survived with the addition of serum and attachment to
the ECM. The cells which survived after HQ-treatment
could be maintained in culture for more than 48 h (Fig.
7B). A significant increase in 8-oxo-dG was found in the
viable cells following treatment with BQ or HQ (Fig. 8).
Furthermore, the cells which survived after treatment with
HQ were again treated with HQ, a process which was
repeated three times once a week. Normal NIH3T3 cells
and surviving cells were cultured under low-serum condi-
tions. The cells which survived showed greater proliferation
than normal cells at a 0.2% or 1% concentration of serum
(Fig. 9). The colony-forming ability in soft agar was veryFig. 7. Survival of the cells treated with HQ or BQ. The cells plated in BSA-coated
for 22 h in serum-free and non-adherent conditions. Then, CS was added and the ce
taken 24 h after addition of CS and attachment to the ECM and cell survival (B) w
HQ; (x) 100 AM HQ; (E) 200 AM HQ. Values are meansF S.D. (n= 3). *P < 0poor in normal NIH3T3 cells and significantly increased in
the surviving cells (Fig. 10). These findings showed that the
cells treated with BQ or HQ survived accompanying in-dishes were treated with HQ or BQ for 2 h, washed out and further cultured
lls were further cultured in the adherent state for 48 h. Photographs (A) were
as assayed as described in the legend to Fig. 1. (n) Untreated; (.) 50 AM
.01, **P< 0.001 (vs. untreated).
Fig. 9. Growth curve of the cells which survived following treatment with
HQ under low-serum conditions. The cells which survived from apoptotic
cell death following treatment with HQ were cultured for a further week in
the presence of CS and ECM. Depletion of CS under non-adherent
conditions and HQ-treatment was repeated three times once a week. Normal
NIH3T3 cells and the cells which survived following treatment with HQ
(1104 cells/100 Al/96 well) were cultured in several concentrations of
serum for 6 h, then incubated with Alamar Blue (10 Al). After incubation
for 4 h, the fluorescence intensity was measured using a microplate
fluorescence reader (FL500, BIO-TEC) (ex. 530 nm, em. 590 nm) at 24-
h intervals. (n) Normal in 0.2% CS; (5) HQ in 0.2% CS; (E) normal in
1% CS; (D) HQ in 1% CS; (.) normal in 2% CS; (o) HQ in 2% CS.
Values are meansF S.D. (n= 8). *P< 0.001 (normal NIH3T3 cells vs. the
cells which survived following HQ-treatment).
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initiation of cancer induced by exposure to benzene, and
that the high growth rate under low-serum conditions and
anchorage-independent growth in soft agar might relate to
transformation that is independent of nutrition and to the
anchorage of malignant cells.4. Discussion
Apoptosis is a physiological cell suicide program that is
critical for the development and maintenance of healthy
tissues. Dysregulation of apoptosis contributes to tumor
progression and malignancy because of accumulation of
gene mutation and genetic instability [15–17]. Antiapop-
totic effectors such as bcl-2, bcl-xL, and survivin, were up-
regulated in their protein expressions in cancer cells like
leukemia and carcinoma [26–29], while apoptosis inducers
such as Bax, Bak, and Apaf-1, were down-regulated or
some of their genes were mutated in colon cancer and in
malignant melanoma [30–32]. Therefore, dysregulated ap-
optosis is one of the mechanisms producing cancer, and this
understanding is critical to the development of better treat-
ments for cancer.
Benzene is known to cause leukemia, lymphoma in
humans and animals, through its metabolites hydroquinone,1,4-benzoquinone, 1,2,4-benzentriol and so on [8–10].
Several studies have demonstrated that these metabolites
can cause DNA damage including strand breaks and oxida-
tion [9,10], the repair of which induces mutations, correlat-
ing with the carcinogenesis of benzene [19–21,33].
However, there is only one approach which encompasses
the dysregulation of apoptosis by benzene [22], the signif-
icance of which is recognized as described above. We have
reported that a low dose of UVB irradiation prevents
apoptosis induced by the detachment of cells from the
ECM under conditions of serum depletion [12] and consid-
ered that this method for apoptotic induction might be
effective in detecting whether benzene metabolites induce
antiapoptotic effects and making clear their relationships
with the carcinogenesis. Both BQ and HQ at a concentration
of 30 and 100 AM prevented apoptosis induced by detach-
ment from the ECM following serum depletion in a dose-
dependent manner. We treated the cells for only 2 h, washed
out and continued the culture in the absence of BQ and HQ.
If BQ and HQ are continuously treated at concentrations
lower than 30 AM, we might detect the suppression of
apoptosis. The relationship with concentration and incuba-
tion time in antiapoptotic effect should be studied in the
future. Benzene metabolites above 100 AM induced cell
death dose-dependently. The cell death is considered to be
necrotic because chromatin-condensation, DNA fragmenta-
tion (Fig. 2A) and caspase-3 activation (Fig. 3) were not
found in spite of the obvious cell death induction at
concentrations of 300 and 1000 AM (Fig. 1). BQ- and
HQ-treatment at 30 and 100 AM allowed the cells to survive
in the suspension. For epithelial malignancies, most cancer
cells have exceedingly low survival rates in the circulation,
whereas metastatic cancer cells survive in a non-adherent
state [34]. A critical attribute of the metastatic cell is its
acquired ability to survive in a non-adherent state. There-
fore, it is important to examine the mechanisms of BQ- and
HQ-induced survival of cells in a non-adherent state and
relationship with carcinogenesis.
The toxicity of benzene is reported to be mainly due to
the production of ROS [7–9]. The treatment with BQ or HQ
resulted in significant intracellular peroxidation. Benzene
metabolites were reported to produce O2
 and H2O2 via the
formation of the semiquinone radical [9]. NAC, an antiox-
idant agent, inhibited the increase in intercellular peroxida-
tion. Considering that NAC significantly prevented the
inhibition of cell death and suppression of caspase-3 acti-
vation, the antiapoptotic effects by HQ and BQ were
attributed to ROS production. Furthermore, HQ and BQ
inhibited the activation of caspase-3 in vitro, indicating that
both metabolites directly suppressed the activation. Cas-
pases, cysteine-containing aspartic acid-specific proteases,
are redox-sensitive enzymes [35,36] and their activities are
inhibited in the presence of thiol-oxidizing agents [37,38]
and enhanced in the presence of dithiothreitol or thioredoxin
[39,40]. The ROS produced by the treatment with BQ or
HQ was considered to oxidize the cysteine residue, which
Fig. 10. Colony formation in soft-agar. Normal NIH3T3 cells and the cells which survived from apoptotic cell death following treatment with HQ (50, 100 AM)
were seeded in 0.3% agar in DMEM supplemented with 10% CS over a cushion of 0.6% agar also in DMEM. After 3 weeks, the plates were photographed (A)
and colonies were enumerated (B). Values are meansF S.D. (n= 5). *P < 0.001 (vs. normal NIH3T3 cells).
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caspase-3 in vitro.
The cells which survived from apoptotic cell death
following treatment with BQ or HQ were kept viable by
the addition of CS and attachment to the ECM 24 h after
apoptosis was induced. The surviving cells had a signifi-
cantly increased amount of 8-oxo-dG in their DNA. 8-oxo-
dG, an oxidative product of the guanine residue, is closely
involved in mutation and carcinogenesis [11,41]. Treat-
ment with benzene metabolites has been reported to
produce 8-oxo-dG [10]. Kuo et al. [42] showed that
suppression of apoptosis by overexpression of bcl-2 en-
hanced benzene-induced oxidative DNA damage. Our
findings suggested that the cells which escaped apoptosis
on treatment with BQ or HQ also contained enhanced
oxidative DNA. Some reports have shown that BQ or HQ
caused certain kinds of mutations, base substitutions,
deletions and sequence-specific frameshifts, in association
with tumor transformation [20]. BQ- or HQ-induced inhi-
bition of apoptosis might keep mutations caused by
themselves. In addition, continuous treatment with benzene
metabolites might accelerate the carcinogenesis of mutated
cells. The thrice weekly treatments with HQ induced
strong growth under low-serum conditions and colony-
formation in soft agar. Malignant transformation is known
to result in a decrease in the requirement for serum,
disappearance of contact inhibition and anchorage-depen-
dency [43–45]. Therefore, the antiapoptotic effects of ben-zene metabolites would be associated with benzene-induced
transformation activity, which had been considered only
from the aspect of benzene-induced DNA damage and
mutation [20,44].
In conclusion, benzene metabolites induce an antiapop-
totic effect, which leads to an accumulation of DNA damage
in surviving cells. The effect was mainly due to the
production of ROS by benzene metabolites. The present
study first proposes that dysregulation of apoptosis by
benzene metabolites might relate to their carcinogenesis.
The effect of benzene-induced dysregulation of apoptosis on
the metastasis or malignancy of cancer requires further
investigation.Acknowledgements
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